west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "肝外胆管癌" 2 results
  • Systematic Evaluation on Relationship Between Viral Hepatitis and Extrahepatic Cholangiocarcinoma

    ObjectiveTo explore the association between viral hepatitis and extrahepatic cholangiocarcinoma (ECC). MethodsDatabase of Medline, Embase, PubMed, CNKI, and Wanfang were searched for the articles which were related to the relationship between viral hepatitis and ECC. After the quality evaluation and the data extraction of the literatures, statistical software of RevMan 5.0 was used to perform Meta analysis. ResultsAccording to the inclusion criteria and exclusion criteria, 9 articles were enrolled, 8 articles of them were related to hepatitis B virus(HBV) and 6 articles of them were related to hepatitis C virus(HCV). Meta analysis results showed that the HBV infection may be the risk factor for ECC(OR=1.69, 95% CI:1.32-2.17, P<0.000 1). In the United States, HCV infection may be the risk factor for ECC(OR=5.53, 95% CI:2.21-13.82, P=0.000 3), but the relationship was not found in China(OR=0.82, 95% CI:0.44-1.52, P=0.520 0). ConclusionsThe present studies suggest that HBV infection may be a high risk factor for ECC. HCV in the United States can increase the incidence of ECC, but the situation can not be found in China.

    Release date: Export PDF Favorites Scan
  • 光动力疗法联合胆道支架与125I粒子支架在不可切除肝外胆管癌的疗效对比研究

    目的对比分析光动力疗法(photodynamic therapy,PDT)联合胆道支架和125I粒子支架治疗晚期肝外胆管癌患者的疗效。 方法回顾性收集2015年1月1日至2023年12月31日期间新疆医科大学第一附属医院收治的32例肝门部胆管癌(Bisnmuth Ⅰ ~Ⅱ型)或胆总管中下段癌患者的临床资料,根据治疗方法的不同分为PDT联合胆道支架组(简称PDT+支架组,9例)和125I粒子支架组(23例),比较2组患者在手术时间、总住院时间、术后并发症发生率、支架通畅时间和生存时间方面的差异。 结果PDT+支架组的手术时间为(83.00±38.40)min,125I粒子支架组的手术时间为(73.70±30.12)min,PDT+支架组的手术时间略长于125I粒子支架组,但差异无统计学意义(P=0.471); PDT+支架组的总住院时间长于125I粒子支架组 [15.0(11.5,17.5)d 比 9.0(7.0,12.0)d],2组间的差异有统计学意义(P=0.038)。PDT+支架组术后出现并发症2例(22.2%),125I粒子支架组术后出现并发症3例(13.0%),2组间的差异无统计学意义(P=0.604)。PDT+支架组的中位支架通畅时间和中位生存时间均长于125I粒子支架组 [8.0(4.5,10.0)个月比 7.0(4.0,11.0)个月;10.0(7.3,13.5)个月比 8.0(5.0,12.0)个月],但2组间的差异均无统计学意义(P>0.05)。结论单次PDT联合胆道支架治疗晚期胆管癌在延长支架通畅时间和生存时间方面具有一定优势,但其有效性和安全性与125I粒子支架治疗差异并不显著。

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content